RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
62 hedge funds and large institutions have $29.7M invested in Rubius Therapeutics, Inc in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 26 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
65% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 26
Holders
62
Holding in Top 10
2
Calls
$25K
Puts
–
Top Buyers
| 1 | +$236K | |
| 2 | +$111K | |
| 3 | +$82.7K | |
| 4 |
BlackRock
New York
|
+$70.1K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$22K |
Top Sellers
| 1 | -$1.88M | |
| 2 | -$720K | |
| 3 | -$564K | |
| 4 |
AFM
Abbot Financial Management
Andover,
Massachusetts
|
-$414K |
| 5 |
Renaissance Technologies
New York
|
-$304K |